Epidermal growth factor/TNF-α transactivation modulates epithelial cell proliferation and apoptosis in a mouse model of parenteral nutrition
- 1 January 2012
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 302 (2), G236-G249
- https://doi.org/10.1152/ajpgi.00142.2011
Abstract
Epidermal growth factor (EGF) and tumor necrosis factor-α (TNF-α) signaling are critical for effective proliferative and apoptotic actions; however, little is known about the codependency of these signaling pathways in the intestinal epithelium. Because total parenteral nutrition (TPN) is associated with loss of intestinal epithelial cell (IEC) proliferation and increased apoptosis, we utilized a mouse model to explore these transactivation pathways in small bowel epithelium. Mice underwent intravenous cannulation and were given enteral nutrition or TPN for 7 days. Outcomes included IEC proliferation, apoptosis, and survival. To address transactivation or dependence of EGF and TNF on IEC physiology, TNF-α receptor knockout (KO) mice, TNFR1-KO, R2-KO, or R1R2-double KO, were used. Exogenous EGF and pharmacological blockade of ErbB1 were performed in other groups to examine the relevance of the ErB1 pathway. TPN increased IEC TNFR1 and decreased EGF and ErbB1 abundance. Loss of IEC proliferation was prevented by exogenous EGF or blockade of TNFR1. However, EGF action was prevented without effective TNFR2 signaling. Also, blockade of TNFR1 could not prevent loss of IEC proliferation without effective ErbB1 signaling. TPN increased IEC apoptosis and was due to increased TNFR1 signaling. Exogenous EGF or blockade of TNFR1 could prevent increased apoptosis, and both pathways were dependent on effective ErbB1 signaling. Exogenous EGF prevented increased apoptosis in mice lacking TNFR2 signaling. TPN mice had significantly decreased survival vs. controls, and this was associated with the TNFR1 signaling pathway. We concluded that these findings identify critical mechanisms that contribute to TPN-associated mucosal atrophy via altered TNF-α/EGF signaling. It emphasizes the importance of both TNFR1 and TNFR2 pathways, as well as the strong interdependence on an intact EGF/ErbB1 pathway.Keywords
This publication has 37 references indexed in Scilit:
- Tumor Necrosis Factor Receptor Expression and Signaling in Renal Cell CarcinomaThe American Journal of Pathology, 2010
- Regeneration of intestinal stem/progenitor cells following doxorubicin treatment of miceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- The Bone Morphogenetic Protein Signaling Pathway Is Upregulated in a Mouse Model of Total Parenteral NutritionJournal of Nutrition, 2009
- The ErbB4 Growth Factor Receptor Is Required for Colon Epithelial Cell Survival in the Presence of TNFGastroenterology, 2009
- Dissociation of E‐cadherin and β‐catenin in a mouse model of total parenteral nutrition: a mechanism for the loss of epithelial cell proliferation and villus atrophyThe Journal of Physiology, 2009
- Intestinal Specific Overexpression of Interleukin-7 Attenuates the Alternation of Intestinal Intraepithelial Lymphocytes After Total Parenteral Nutrition AdministrationAnnals of Surgery, 2008
- Transactivation of EGF receptor and ErbB2 protects intestinal epithelial cells from TNF-induced apoptosisProceedings of the National Academy of Sciences of the United States of America, 2008
- Tumor necrosis factor inhibits ligand-stimulated EGF receptor activation through a TNF receptor 1-dependent mechanismAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- Parenteral Nutrition Impairs Gut-Associated Lymphoid Tissue and Mucosal Immunity by Reducing Lymphotoxin β Receptor ExpressionAnnals of Surgery, 2006
- EGF–ERBB signalling: towards the systems levelNature Reviews Molecular Cell Biology, 2006